A detailed history of J. Safra Sarasin Holding Ag transactions in Annexon, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 117,768 shares of ANNX stock, worth $336,816. This represents 0.01% of its overall portfolio holdings.

Number of Shares
117,768
Previous 223,221 47.24%
Holding current value
$336,816
Previous $681 Million 13.16%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 15, 2026

SELL
$2.68 - $3.54 $282,614 - $373,303
-105,453 Reduced 47.24%
117,768 $591 Million
Q3 2025

Nov 03, 2025

SELL
$2.05 - $3.37 $324,351 - $533,201
-158,220 Reduced 41.48%
223,221 $681 Million
Q2 2025

Jul 21, 2025

BUY
$1.38 - $2.73 $175,126 - $346,445
126,903 Added 49.86%
381,441 $915 Million
Q1 2025

May 09, 2025

BUY
$1.93 - $5.5 $190,672 - $543,367
98,794 Added 63.43%
254,538 $491 Million
Q4 2024

Feb 14, 2025

BUY
$4.44 - $7.63 $691,503 - $1.19 Million
155,744 New
155,744 $799 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $136M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track J. Safra Sarasin Holding Ag Portfolio

Follow J. Safra Sarasin Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Safra Sarasin Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on J. Safra Sarasin Holding Ag with notifications on news.